Tranzyme Pharma Announces Presentation of Additional Data for Its Oral Drug Candidate, TZP-102, at Annual Neurodiab Meeting in Porto, Portugal
September 12, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Niels Ejskjaer, M.D., Ph.D., Department of Endocrinology M, Aarhus University...
Tranzyme Pharma to Present at Upcoming Investor Conferences
September 07, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 7, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq: TZYM), today announced that Vipin Garg, President and CEO and Richard Eisenstadt, CFO will present at the...
Tranzyme Pharma Announces Management Change
August 25, 2011 16:30 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that Gordana Kosutic, M.D. has resigned as Vice President, Clinical and Regulatory...
Brent Bankosky Joins Tranzyme Pharma as Vice President, Business Development
August 18, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that Brent Bankosky has joined the Company as Vice President, Business Development. In his...
Tranzyme Pharma Announces Second Quarter 2011 Financial Results
August 11, 2011 16:30 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a clinical stage biopharmaceutical company focused on discovering, developing and commercializing novel,...
David Moore Joins Tranzyme Pharma as Vice President, Commercial Operations
August 09, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that David Moore has joined the Company as Vice President, Commercial Operations, a newly...
Tranzyme Pharma to Report Second Quarter 2011 Financial Results
August 02, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 2, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will report second quarter 2011 financial results after the close of the market on...
Tranzyme Pharma to Present at Canaccord Genuity Annual Growth Conference
July 28, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., July 28, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a late-stage biopharmaceutical company, today announced that Vipin Garg, President and CEO, and Richard...
Tranzyme Pharma's Richard Eisenstadt Wins Triangle Business Journal CFO of the Year Award
July 20, 2011 05:10 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that its Chief Financial Officer, Richard Eisenstadt, has been honored as a Triangle...
Tranzyme Pharma Announces First Quarter 2011 Financial Results
May 12, 2011 16:01 ET
|
Tranzyme, Inc.
RESEARCH TRIANGLE PARK, N.C., May 12, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a clinical‑stage biopharmaceutical company focused on discovering, developing and commercializing...